Published in Graefes Arch Clin Exp Ophthalmol on January 26, 2005
Structural alterations of the erythrocyte membrane proteins in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2007) 0.78
Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature (1962) 18.89
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology (2003) 8.98
Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators. JAMA (1992) 2.52
Observations on the change in shape of blood platelets brought about by adenosine diphosphate. J Physiol (1970) 1.81
Platelet dysfunction in type 2 diabetes. Diabetes Care (2001) 1.66
Development of large platelet aggregates from small aggregates as determined by laser-light scattering: effects of aggregant concentration and antiplatelet medication. Thromb Haemost (1996) 1.44
Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering. Am J Ophthalmol (2004) 1.44
Increased platelet aggregation in early diabetus mellitus. Ann Intern Med (1975) 1.40
Effect of low concentration of epinephrine on human platelet aggregation analyzed by particle counting method and confocal microscopy. J Lab Clin Med (1997) 1.39
Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med (1981) 1.20
Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. The DAMAD Study Group. Diabetes (1989) 1.10
Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res (1999) 0.99
Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem (1994) 0.99
Formation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease. Thromb Haemost (2003) 0.87
Sex difference in platelet aggregation detected by new aggregometry using light scattering. Endocr J (2001) 0.87
Rapid change of platelet aggregability in acute hyperglycemia. Detection by a novel laser-light scattering method. Thromb Haemost (2000) 0.85
Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates. Br J Pharmacol (1999) 0.85
Platelet function in diabetes mellitus. Diabetes Metab Rev (1992) 0.85
Platelet aggregation in type I diabetics with and without proliferative retinopathy. Acta Ophthalmol (Copenh) (1987) 0.84
A cross-sectional evaluation of spontaneous platelet aggregation in relation to complications in patients with type II diabetes mellitus. Metabolism (1998) 0.82
Changes of platelet function and blood clotting in diabetes mellitus. Thromb Haemost (1979) 0.81
Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation. Diabetes (1997) 0.81
Reduction in single platelets during primary and secondary aggregation. Thromb Haemost (1981) 0.79
Ticlopidine treatment reduces the progression of nonproliferative diabetic retinopathy. The TIMAD Study Group. Arch Ophthalmol (1990) 0.79
A new system to detect native microaggregates of platelets in vivo, with a novel platelet aggregometer employing laser light scattering. Thromb Res (1998) 0.77
Optical density variations and microscopic observations in the evaluation of platelet shape change and microaggregate formation. Thromb Haemost (1980) 0.77
Will blocking the platelet save the diabetic? Circulation (2000) 0.76
Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A (2002) 6.47
The IC3D classification of the corneal dystrophies. Cornea (2008) 3.46
Midterm results on ocular surface reconstruction using cultivated autologous oral mucosal epithelial transplantation. Am J Ophthalmol (2006) 2.51
Argon laser iridotomy-induced bullous keratopathy a growing problem in Japan. Br J Ophthalmol (2007) 2.44
The ROCK inhibitor eye drop accelerates corneal endothelium wound healing. Invest Ophthalmol Vis Sci (2013) 2.30
Corneal transplantation. Lancet (2012) 2.13
Dissemination of methicillin-resistant staphylococci among healthy Japanese children. J Clin Microbiol (2005) 2.13
Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci U S A (2010) 2.07
Tractography to depict three layers of visual field trajectories to the calcarine gyri. Am J Ophthalmol (2005) 2.03
Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology (2008) 1.96
ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue. Am J Pathol (2012) 1.85
Clinicopathologic study of conjunctivochalasis. Cornea (2004) 1.84
Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol (2011) 1.83
The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci (2011) 1.80
Long-term results of autologous cultivated oral mucosal epithelial transplantation in the scar phase of severe ocular surface disorders. Br J Ophthalmol (2010) 1.77
New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. Ophthalmology (2007) 1.71
LOXL1 genetic polymorphisms are associated with exfoliation glaucoma in the Japanese population. Mol Vis (2008) 1.61
Intracellularly expressed TLR2s and TLR4s contribution to an immunosilent environment at the ocular mucosal epithelium. J Immunol (2004) 1.60
The presence of Propionibacterium spp. in the vitreous fluid of uveitis patients with sarcoidosis. Acta Ophthalmol Scand (2005) 1.56
Amniotic membrane as a carrier for cultivated human corneal endothelial cell transplantation. Invest Ophthalmol Vis Sci (2004) 1.55
Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema. Acta Ophthalmol (2008) 1.55
Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. Br J Ophthalmol (2007) 1.53
Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol (2007) 1.53
Three susceptible loci associated with primary open-angle glaucoma identified by genome-wide association study in a Japanese population. Proc Natl Acad Sci U S A (2009) 1.51
HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics (2008) 1.49
Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci (2013) 1.48
Design of metal cofactors activated by a protein-protein electron transfer system. Proc Natl Acad Sci U S A (2006) 1.47
Triggering of TLR3 by polyI:C in human corneal epithelial cells to induce inflammatory cytokines. Biochem Biophys Res Commun (2005) 1.46
Nonaxoplasmic transfer of indocyanine green into the optic nerve after intravitreal application. Retina (2004) 1.44
Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering. Am J Ophthalmol (2004) 1.44
The features of dry eye disease in a Japanese elderly population. Optom Vis Sci (2006) 1.41
Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor. Invest Ophthalmol Vis Sci (2009) 1.40
IC3D classification of corneal dystrophies--edition 2. Cornea (2015) 1.39
Prevalence of dry eye disease and its risk factors in visual display terminal users: the Osaka study. Am J Ophthalmol (2013) 1.37
Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration. Mol Vis (2007) 1.33
National survey on bullous keratopathy in Japan. Cornea (2007) 1.33
Characterization and distribution of bone marrow-derived cells in mouse cornea. Invest Ophthalmol Vis Sci (2005) 1.33
Tight junction-related protein expression and distribution in human corneal epithelium. Exp Eye Res (2003) 1.30
Testing of semichronically implanted retinal prosthesis by suprachoroidal-transretinal stimulation in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci (2011) 1.30
Optical coherence tomographic findings of macular holes and retinal detachment after vitrectomy in highly myopic eyes. Am J Ophthalmol (2003) 1.30
Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1. EMBO J (2007) 1.28
Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride. J Glaucoma (2003) 1.28
Identification of human oral keratinocyte stem/progenitor cells by neurotrophin receptor p75 and the role of neurotrophin/p75 signaling. Stem Cells (2006) 1.25
Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea. Cornea (2002) 1.24
An evaluation of cultivated corneal limbal epithelial cells, using cell-suspension culture. Invest Ophthalmol Vis Sci (2002) 1.23
Establishment of a cultivated human conjunctival epithelium as an alternative tissue source for autologous corneal epithelial transplantation. Invest Ophthalmol Vis Sci (2006) 1.23
Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study. Ophthalmology (2012) 1.22
Predicted phenotypes of dry eye: proposed consequences of its natural history. Ocul Surf (2009) 1.21
Extreme genetic diversity of methicillin-resistant Staphylococcus epidermidis strains disseminated among healthy Japanese children. J Clin Microbiol (2008) 1.21
Association between prostaglandin E receptor 3 polymorphisms and Stevens-Johnson syndrome identified by means of a genome-wide association study. J Allergy Clin Immunol (2010) 1.20
Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results. Ophthalmology (2012) 1.19
Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology (2007) 1.18
The successful culture and autologous transplantation of rabbit oral mucosal epithelial cells on amniotic membrane. Invest Ophthalmol Vis Sci (2003) 1.18
Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology (2009) 1.18
Vitrectomy and internal limiting membrane peeling for myopic foveoschisis. Am J Ophthalmol (2004) 1.17
HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Epilepsia (2010) 1.16
Cultivated corneal endothelial cell sheet transplantation in a primate model. Invest Ophthalmol Vis Sci (2007) 1.16
Chronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degeneration. J Cell Sci (2012) 1.15
Wide-angle viewing lens for vitrectomy. Am J Ophthalmol (2004) 1.14
Sterilized, freeze-dried amniotic membrane: a useful substrate for ocular surface reconstruction. Invest Ophthalmol Vis Sci (2004) 1.14
Evaluation of phosphenes elicited by extraocular stimulation in normals and by suprachoroidal-transretinal stimulation in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol (2007) 1.12
Genetic polymorphisms in the promoter of the interferon gamma receptor 1 gene are associated with atopic cataracts. Invest Ophthalmol Vis Sci (2007) 1.12
Controlled-release of epidermal growth factor from cationized gelatin hydrogel enhances corneal epithelial wound healing. J Control Release (2006) 1.12
Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability. Am J Ophthalmol (2012) 1.12
A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye. Ophthalmology (2013) 1.10
Common variants in CDKN2B-AS1 associated with optic-nerve vulnerability of glaucoma identified by genome-wide association studies in Japanese. PLoS One (2012) 1.10
Comparison of ultrastructure, tight junction-related protein expression and barrier function of human corneal epithelial cells cultivated on amniotic membrane with and without air-lifting. Exp Eye Res (2003) 1.09
Cytomegalovirus in aqueous humor from an eye with corneal endotheliitis. Am J Ophthalmol (2006) 1.09
Tumor-associated calcium signal transducer 2 is required for the proper subcellular localization of claudin 1 and 7: implications in the pathogenesis of gelatinous drop-like corneal dystrophy. Am J Pathol (2010) 1.09
Connexin43 knockdown accelerates wound healing but inhibits mesenchymal transition after corneal endothelial injury in vivo. Invest Ophthalmol Vis Sci (2008) 1.09
Tight junction transmembrane protein claudin subtype expression and distribution in human corneal and conjunctival epithelium. Invest Ophthalmol Vis Sci (2008) 1.08
Clinical impact of conjunctivochalasis on the ocular surface. Cornea (2005) 1.08
Hes1 regulates corneal development and the function of corneal epithelial stem/progenitor cells. Stem Cells (2008) 1.08
Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset. Am J Ophthalmol (2009) 1.08
Strong association between HLA-A*0206 and Stevens-Johnson syndrome in the Japanese. Am J Ophthalmol (2006) 1.08
cDNA microarray analysis of gene expression changes induced by dexamethasone in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci (2002) 1.07
Autologous serum-derived cultivated oral epithelial transplants for severe ocular surface disease. Arch Ophthalmol (2006) 1.07
Inhibition of TGF-β signaling enables human corneal endothelial cell expansion in vitro for use in regenerative medicine. PLoS One (2013) 1.07
Enhancement of corneal endothelium wound healing by Rho-associated kinase (ROCK) inhibitor eye drops. Br J Ophthalmol (2011) 1.06
Neural conversion of ES cells by an inductive activity on human amniotic membrane matrix. Proc Natl Acad Sci U S A (2006) 1.05
Development of new therapeutic modalities for corneal endothelial disease focused on the proliferation of corneal endothelial cells using animal models. Exp Eye Res (2011) 1.05
Spontaneous ocular surface inflammation and goblet cell disappearance in I kappa B zeta gene-disrupted mice. Invest Ophthalmol Vis Sci (2005) 1.05
Development and validation of the Dry Eye-Related Quality-of-Life Score questionnaire. JAMA Ophthalmol (2013) 1.05